Transforming Nanoparticles By Continuous Manufacturing

Lipid nanoparticles (LNPs) are poised to change the landscape of drug delivery and therapeutic applications. However, the use of batch processes for manufacturing can lead to inconsistencies in product quality, as well as higher costs. Continuous manufacturing is a streamlined, closed-loop process that can improve process efficiency and yield, reduce costs, and increase the quality of the end-product.

This webinar details how a turnkey solution for continuous manufacturing can improve the production of various types of nanoparticles. Find out how different systems—ranging from benchtop to large-scale, high-throughput systems—can enhance the production of high-quality drug products in GMP facilities.

Produced by American Pharmaceutical Review.